Botox Linked To Adverse Reactions, Sometimes Death, Says FDA
Feb 11th 2008Drug InformationNeurology / Neuroscience
Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) have been associated with undesirable side-effects, including respiratory failure, and on occasions death, says the US Food and Drug Administration (FDA). These adverse reactions can occur after treatment for a range of conditions and dosages. These reactions may be caused by overdosing, the FDA reports in an early communication based on its ongoing safety review.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
